Daniel L. Flynn,Michael D. Kaufman,FLYNN, Daniel L.,PETILLO, Peter A.,KAUFMAN, Michael D.,BOOTH, Richard John
申请号：
US13228288
公开号：
US20120225057A1
申请日:
2011.09.08
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Compounds of the present invention, alone and in combination with other active agents, find utility in the treatment of hyperproliferative diseases, mammalian cancers and especially human cancers including but not limited to for example malignant melanomas, myeloproliferative diseases, chronic myelogenous leukemia, acute lymphocytic leukemia, a disease caused by c-ABL kinase, oncogenic forms thereof, aberrant fusion proteins thereof and polymorphs thereof.
